MultiCASE, Inc. Information

Welcome to MultiCASE, Inc.! We take immense pride in being the leading provider of state-of-the-art artificial intelligence-based software, expert systems, and in silico consulting services tailored for regulatory agencies, academia, and the chemical and pharmaceutical industries. Our journey began in 1996 in Cleveland, Ohio, founded by the visionary minds of Gilles Klopman, the Charles F. Mabery Professor of Chemistry at Case Western Reserve University (CWRU), along with Roustem D Saiakhov and Suman Chakravarti. With a relentless pursuit of excellence, we have been transforming the landscape of chemical entity design and early-stage adverse effects evaluation for regulatory agencies, academia, and esteemed chemical and pharmaceutical companies. Our predictive toxicology software, built with cutting-edge technology, enables ICH M7 Step 2 compatible in silico toxicity evaluation of drug candidates, impurities, metabolites, and reagents. Trusted by regulatory agencies, pharma, chemical, and cosmetic companies alike, our software and databases stand as a pillar of support for their critical endeavors. Many of our expert systems are enriched with data developed by the US Food and Drug Administration CDER office, endorsed by various government regulatory agencies, and the OECD in conjunction with the REACH program. At MultiCASE, Inc., we are committed to forging a brighter future through the harmonious synergy of science, technology, and innovation. Join us on this transformative journey as we continue to pave the way for a safer and more sustainable world.